Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model

Veterinary Microbiology

Volumn 171, Issue 1-2, 2014, Pages 93-101

  Wu, Qunfeng ^a   Yu, Fulai ^a   Xu, Jinfang ^a   Li, Yang ^a   Chen, Huanchun ^a   Xiao, Shaobo ^a   Fu, Zhen F ^a,b   Fang, Liurong ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Glycoprotein; Pseudotyped baculovirus; Rabies virus; Vaccine

Indexed keywords

BACULOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; RABIES VACCINE; RECOMBINANT BACULOVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SAFETY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INSECT CELL; LD 50; MAMMAL CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PSEUDOTYPING; RABIES; RABIES VIRUS; SYNCYTIUM; VIRAL GENE DELIVERY SYSTEM;

ANIMALIA; HEXAPODA; MAMMALIA; MUS; RABIES VIRUS;

GLYCOPROTEIN; PSEUDOTYPED BACULOVIRUS; RABIES VIRUS; VACCINE;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELL LINE; CELL LINE, TUMOR; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; RABIES; RABIES VACCINES; RABIES VIRUS; SF9 CELLS; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS;

EID: 84899925953     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.03.037     Document Type: Article

References (46)

1. Abe T., Kaname Y., Wen X., Tani H., Moriishi K., Uematsu S., Takeuchi O., Ishii K.J., Kawai T., Akira S., Matsuura Y. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J. Virol. 2009, 83:7629-7640.
2. Abe T., Takahashi H., Hamazaki H., Miyano-Kurosaki N., Matsuura Y., Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol. 2003, 171:1133-1139.
3. Barsoum J., Brown R., McKee M., Boyce F.M. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Therapy 1997, 8:2011-2018.
4. Both L., Banyard A.C., van Dolleweerd C., Horton D.L., Ma J.K., Fooks A.R. Passive immunity in the prevention of rabies. Lancet Infect. Dis. 2012, 12:397-407.
5. Brzozka K., Finke S., Conzelmann K.K. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J. Virol. 2006, 80:2675-2683.
6. Chen C.Y., Liu H.J., Tsai C.P., Chung C.Y., Shih Y.S., Chang P.C., Chiu Y.T., Hu Y.C. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms. Vaccine 2010, 28:7644-7651.
7. Chen Z., Zhou M., Gao X., Zhang G., Ren G., Gnanadurai C.W., Fu Z.F., He B. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein. J. Virol. 2013, 87:2986-2993.
8. Chopy D., Detje C.N., Lafage M., Kalinke U., Lafon M. The type I interferon response bridles rabies virus infection and reduces pathogenicity. J. Neurovirol. 2011, 17:353-367.
9. Facciabene A., Aurisicchio L., La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J. Virol. 2004, 78:8663-8672.
10. Fan H., Pan Y., Fang L., Wang D., Wang S., Jiang Y., Chen H., Xiao S. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J. Virol. Methods 2008, 150:21-26.
11. Fan H., Xiao S., Tong T., Wang S., Xie L., Jiang Y., Chen H., Fang L. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments. Mol. Immunol. 2008, 45:653-660.
12. Fehlner-Gardiner C., Nadin-Davis S., Armstrong J., Muldoon F., Bachmann P., Wandeler A. Era vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989-2004. J. Wildl. Dis. 2008, 44:71-85.
13. Ge J., Wang X., Tao L., Wen Z., Feng N., Yang S., Xia X., Yang C., Chen H., Bu Z. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J. Virol. 2011, 85:8241-8252.
14. Gronowski A.M., Hilbert D.M., Sheehan K.C., Garotta G., Schreiber R.D. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol. 1999, 73:9944-9951.
15. Guo L., Feng N., Yang S., Wang X., Ge J., Xia X., Bu Z. Reverse genetic system for rabies virus vaccine Evelyn-Rokitnicki-Abelseth strain. Wei sheng wu xue bao=Acta Microbiol. Sin. 2009, 49:949-954.
16. Gupta P.K., Sharma S., Walunj S.S., Chaturvedi V.K., Raut A.A., Patial S., Rai A., Pandey K.D., Saini M. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus. Vet. Microbiol. 2005, 108:207-214.
17. Hervas-Stubbs S., Rueda P., Lopez L., Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 2007, 178:2361-2369.
18. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:10099-10103.
19. Hooper D.C., Morimoto K., Bette M., Weihe E., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 1998, 72:3711-3719.
20. Huang H., Xiao S., Qin J., Jiang Y., Yang S., Li T., Gao Y., Li Z., Su X., Ruan Y., Xu F., Wang H., Chen H., Xia X. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Arch. Virol. 2011, 156:753-758.
21. Jackson A.C. Rabies pathogenesis. J. Neurovirol. 2002, 8:267-269.
22. Johnson N., Cunningham A.F., Fooks A.R. The immune response to rabies virus infection and vaccination. Vaccine 2010, 28:3896-3901.
23. Lees C.Y., Briggs D.J., Wu X., Davis R.D., Moore S.M., Gordon C., Xiang Z., Ertl H.C., Tang D.C., Fu Z.F. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Vet. Microbiol. 2002, 85:295-303.
24. Molinari P., Garcia-Nunez S., Gravisaco M.J., Carrillo E., Berinstein A., Taboga O. Baculovirus treatment fully protects mice against a lethal challenge of FMDV. Antiviral Res. 2010, 87:276-279.
25. Pan Y., Zhao Q., Fang L., Luo R., Chen H., Xiao S. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon. J. Gene Med. 2009, 11:1030-1038.
26. Park S.W., Lee H.K., Kim T.G., Yoon S.K., Paik S.Y. Hepatocyte-specific gene expression by baculovirus pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochem. Biophys. Res. Commun. 2001, 289:444-450.
27. Pieroni L., Maione D., La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum. Gene Therapy 2001, 12:871-881.
28. Prabakaran M., Madhan S., Prabhu N., Qiang J., Kwang J. Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. J. Virol. 2010, 84:3201-3209.
29. Reed L., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27:493-497.
30. Ren J., Sun L., Yang L., Wang H., Wan M., Zhang P., Yu H., Guo Y., Yu Y., Wang L. A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use. Vaccine 2010, 28:2458-2464.
31. Ren L. Molecular characterization of a Chinese variant of the Flury-LEP strain. Virol. J. 2010, 7:80.
32. Saxena S., Dahiya S.S., Sonwane A.A., Patel C.L., Saini M., Rai A., Gupta P.K. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge. Vaccine 2008, 26:6592-6601.
33. Saxena S., Sonwane A.A., Dahiya S.S., Patel C.L., Saini M., Rai A., Gupta P.K. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein. Vet. Microbiol. 2009, 136:36-44.
34. Seligmann E.B. Laboratory Techniques in Rabies: The NIH Test for Potency 1973, 279-286. Monogr Ser World Health Organ.
35. Shwiff S., Hampson K., Anderson A. Potential economic benefits of eliminating canine rabies. Antiviral Res. 2013, 98:352-356.
36. Suzuki T., Chang M.O., Kitajima M., Takaku H. Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses. Cell Immunol. 2010, 262:35-43.
37. Tani H., Limn C.K., Yap C.C., Onishi M., Nozaki M., Nishimune Y., Okahashi N., Kitagawa Y., Watanabe R., Mochizuki R., Moriishi K., Matsuura Y. In vitro and in vivo gene delivery by recombinant baculoviruses. J. Virol. 2003, 77:9799-9808.
38. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., Jiang B., Fu Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 2005, 79:12554-12565.
39. Wen Y., Wang H., Wu H., Yang F., Tripp R.A., Hogan R.J., Fu Z.F. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J. Virol. 2011, 85:1634-1644.
40. Wu Q., Fang L., Wu X., Li B., Luo R., Yu Z., Jin M., Chen H., Xiao S. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Mol. Immunol. 2009, 46:2210-2217.
41. Wu Q., Xiao S., Fan H., Li Y., Xu J., Li Z., Lu W., Su X., Zou W., Jin M., Chen H., Fang L. Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine. Antiviral Res. 2011, 92:493-496.
42. Wu Q., Xu F., Fang L., Xu J., Li B., Jiang Y., Chen H., Xiao S. Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus. J. Virol. Methods 2013, 187:251-258.
43. Yin W., Dong J., Tu C., Edwards J., Guo F., Zhou H., Yu H., Vong S. Challenges and needs for China to eliminate rabies. Infect. Dis. Poverty 2013, 2:23.
44. Zavadova J., Svrcek S., Madar M., Durove A. Titration of rabies antibodies with the rapid fluorescence focus inhibition test. Vet. Med. (Praha) 1996, 41:225-230.
45. Zhang J., Wu X., Zan J., Wu Y., Ye C., Ruan X., Zhou J. Cellular chaperonin CCTgamma contributes to rabies virus replication during infection. J. Virol. 2013, 87:7608-7621.
46. Zhu B., Ye J., Lu P., Jiang R., Yang X., Fu Z.F., Chen H., Cao S. Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus. Virol. J. 2012, 9:132.